AI Engines For more Details: Perplexity Kagi Labs You
Moisturizing: Glycerol is hygroscopic, meaning it can attract and retain moisture from the environment. In skincare products, glycerol is often used as a moisturizer to help hydrate and soften the skin. It can be beneficial for individuals with dry or sensitive skin conditions, such as eczema or psoriasis, by improving skin hydration and reducing dryness and flakiness.
Topical Treatments: Glycerol is frequently used as an ingredient in topical medications and ointments due to its moisturizing properties. It can help soothe and protect the skin, making it suitable for treating minor skin irritations, burns, and wounds. Glycerol-containing products may promote wound healing by keeping the affected area moist and preventing excessive drying.
Constipation Relief: Glycerol suppositories are sometimes used as a gentle laxative to relieve constipation. When inserted into the rectum, glycerol suppositories stimulate bowel movements by drawing water into the intestines and softening the stool, making it easier to pass. Glycerol suppositories are particularly suitable for children and adults who cannot tolerate or prefer to avoid oral laxatives.
Oral Health: Glycerol is commonly found in oral care products such as toothpaste and mouthwash. Its humectant properties help retain moisture in the mouth, preventing dryness and promoting oral hydration. Glycerol-containing mouthwashes may also help soothe oral tissues and provide relief from minor mouth irritations, such as soreness or inflammation.
Cough Remedies: Glycerol is sometimes used as a component in cough syrups and lozenges due to its demulcent properties, which help soothe irritated throat tissues and alleviate coughing. By forming a protective coating on the throat, glycerol can provide temporary relief from cough symptoms associated with conditions such as colds, flu, or respiratory infections.
Hypertonicity Management: In medical emergencies such as hyperosmolar hyperglycemic state (HHS) or diabetic ketoacidosis (DKA), intravenous administration of hypertonic glycerol solutions may be used to lower elevated blood glucose levels and reduce intracranial pressure. Glycerol acts as an osmotic diuretic, drawing excess water out of the body's cells and into the bloodstream, thereby reducing cellular swelling and improving fluid balance.
Skincare and Cosmetics: Glycerol is a common ingredient in skincare and cosmetic products due to its emollient and humectant properties. It helps to improve the texture and feel of formulations, making them smoother and more spreadable. In cosmetics, glycerol is often used in moisturizers, lotions, creams, and makeup products to hydrate the skin and enhance product performance.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Clostridium beijerinckii | Increases |
| species | Clostridium butyricum | Increases |
| species | Faecalibacterium prausnitzii | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 1.7 | 1.2 | 0.42 |
| ADHD | 2.8 | 2.5 | 0.12 |
| Age-Related Macular Degeneration and Glaucoma | 0.7 | 0.7 | |
| Allergic Rhinitis (Hay Fever) | 1.2 | 0.9 | 0.33 |
| Allergies | 4.2 | 3.8 | 0.11 |
| Allergy to milk products | 0.5 | 2.2 | -3.4 |
| Alopecia (Hair Loss) | 0.8 | -0.8 | |
| Alzheimer's disease | 4.2 | 3.3 | 0.27 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 1.6 | -2.2 |
| Ankylosing spondylitis | 0.8 | 1 | -0.25 |
| Anorexia Nervosa | 3.4 | 3.6 | -0.06 |
| Asthma | 2.2 | 2.4 | -0.09 |
| Atherosclerosis | 1.2 | 1.1 | 0.09 |
| Atrial fibrillation | 2.5 | 1.1 | 1.27 |
| Autism | 3.4 | 4.8 | -0.41 |
| Autoimmune Disease | 1.2 | 0.3 | 3 |
| benign prostatic hyperplasia | 0.8 | 0.8 | |
| Bipolar Disorder | 1.6 | 2.8 | -0.75 |
| Brain Trauma | 1.1 | 1.2 | -0.09 |
| Breast Cancer | 0.2 | 0.3 | -0.5 |
| Cancer (General) | 0.7 | 0.7 | |
| Carcinoma | 1.2 | 1.2 | 0 |
| Celiac Disease | 2.8 | 1 | 1.8 |
| Cerebral Palsy | 0.6 | 0.6 | 0 |
| Chronic Fatigue Syndrome | 2.3 | 2.1 | 0.1 |
| Chronic Kidney Disease | 1.3 | 0.3 | 3.33 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.4 | 0.8 | -1 |
| Chronic Urticaria (Hives) | 1.1 | 0.6 | 0.83 |
| Coagulation / Micro clot triggering bacteria | 0.3 | -0.3 | |
| Cognitive Function | 2.1 | 1.6 | 0.31 |
| Colorectal Cancer | 1.8 | 3.7 | -1.06 |
| Constipation | 0.6 | 0.7 | -0.17 |
| Coronary artery disease | 1.8 | 0.9 | 1 |
| COVID-19 | 4.6 | 3.5 | 0.31 |
| Crohn's Disease | 4 | 3.4 | 0.18 |
| cystic fibrosis | 0.8 | 0.8 | |
| deep vein thrombosis | 0.3 | 0.3 | |
| Depression | 5.1 | 3.9 | 0.31 |
| Dermatomyositis | 0.2 | 0.3 | -0.5 |
| Eczema | 1.2 | 2.3 | -0.92 |
| Endometriosis | 0.6 | 1.7 | -1.83 |
| Eosinophilic Esophagitis | 0.9 | 0.9 | |
| Epilepsy | 1.4 | 4.3 | -2.07 |
| erectile dysfunction | 1.1 | 1.1 | 0 |
| Fibromyalgia | 2.5 | 2.5 | 0 |
| Functional constipation / chronic idiopathic constipation | 1.8 | 4.2 | -1.33 |
| gallstone disease (gsd) | 1.2 | 1.2 | 0 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.6 | 0.8 | 1 |
| Generalized anxiety disorder | 1.2 | 0.5 | 1.4 |
| giant cell arteritis | 0.6 | 0.6 | 0 |
| Glioblastoma | 1.3 | 0.3 | 3.33 |
| Gout | 1.7 | 0.9 | 0.89 |
| Graves' disease | 3 | 3 | |
| Gulf War Syndrome | 0.5 | 0.6 | -0.2 |
| Halitosis | 0.6 | -0.6 | |
| Hashimoto's thyroiditis | 1.3 | 1.4 | -0.08 |
| Heart Failure | 1.6 | 1.5 | 0.07 |
| hemorrhagic stroke | 1.2 | 1.6 | -0.33 |
| Hemorrhoidal disease, Hemorrhoids, Piles | 0.3 | -0.3 | |
| Hidradenitis Suppurativa | 0.3 | 0.3 | |
| High Histamine/low DAO | 0.6 | 0.9 | -0.5 |
| hypercholesterolemia (High Cholesterol) | 0.6 | 1.2 | -1 |
| hyperglycemia | 0.5 | 1.1 | -1.2 |
| Hyperlipidemia (High Blood Fats) | 1.7 | 1.7 | |
| hypersomnia | 0.7 | 0.7 | |
| hypertension (High Blood Pressure | 2.7 | 1.5 | 0.8 |
| Hypothyroidism | 1.6 | 1.1 | 0.45 |
| Hypoxia | 0.8 | 0.9 | -0.13 |
| IgA nephropathy (IgAN) | 2.2 | 1.3 | 0.69 |
| Inflammatory Bowel Disease | 5.7 | 3.2 | 0.78 |
| Insomnia | 0.8 | 0.8 | 0 |
| Intelligence | 0.5 | 1.6 | -2.2 |
| Intracranial aneurysms | 0.9 | 1.4 | -0.56 |
| Irritable Bowel Syndrome | 5 | 4.1 | 0.22 |
| ischemic stroke | 3 | 1.5 | 1 |
| Juvenile idiopathic arthritis | 0.3 | -0.3 | |
| Liver Cirrhosis | 2.1 | 3.2 | -0.52 |
| Long COVID | 5.1 | 3.3 | 0.55 |
| Low bone mineral density | 1.3 | 1.3 | |
| Lung Cancer | 2.6 | 0.3 | 7.67 |
| Lymphoma | 0.9 | 0.9 | |
| Mast Cell Issues / mastitis | 1.1 | 1.1 | |
| ME/CFS with IBS | 1.1 | 1.5 | -0.36 |
| ME/CFS without IBS | 1.2 | -1.2 | |
| Menopause | 0.9 | 0.9 | |
| Metabolic Syndrome | 5.4 | 3.9 | 0.38 |
| Mood Disorders | 4.6 | 6.4 | -0.39 |
| multiple chemical sensitivity [MCS] | 0.5 | 0.5 | |
| Multiple Sclerosis | 2.8 | 5.3 | -0.89 |
| Multiple system atrophy (MSA) | 0.5 | -0.5 | |
| myasthenia gravis | 2.4 | 1.1 | 1.18 |
| neuropathic pain | 1.7 | 1.7 | |
| Neuropathy (all types) | 1 | 1.1 | -0.1 |
| neuropsychiatric disorders (PANDAS, PANS) | 1.4 | 0.3 | 3.67 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.3 | 2.9 | 0.14 |
| NonCeliac Gluten Sensitivity | 0.6 | 0.2 | 2 |
| Obesity | 7 | 5.1 | 0.37 |
| obsessive-compulsive disorder | 1.9 | 1.2 | 0.58 |
| Osteoarthritis | 1.1 | 2.1 | -0.91 |
| Osteoporosis | 1.8 | 2.5 | -0.39 |
| pancreatic cancer | 1 | 0.2 | 4 |
| Parkinson's Disease | 3.9 | 6.2 | -0.59 |
| Peanut Allergy | 1.4 | 1.4 | |
| Polycystic ovary syndrome | 3.6 | 3.4 | 0.06 |
| Postural orthostatic tachycardia syndrome | 0.6 | -0.6 | |
| Premenstrual dysphoric disorder | 0 | 0 | |
| primary biliary cholangitis | 2.2 | 0.8 | 1.75 |
| Primary sclerosing cholangitis | 3 | 0.6 | 4 |
| Psoriasis | 0.6 | 1.8 | -2 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.7 | 4.1 | -0.11 |
| Rosacea | 1.4 | 0.1 | 13 |
| Schizophrenia | 2.2 | 4.1 | -0.86 |
| scoliosis | 0.7 | -0.7 | |
| sensorineural hearing loss | 0.5 | 0.3 | 0.67 |
| Sjögren syndrome | 2.5 | 1.7 | 0.47 |
| Sleep Apnea | 1.5 | 0.5 | 2 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 2.5 | -2.5 | |
| Stress / posttraumatic stress disorder | 1.9 | 1.2 | 0.58 |
| Systemic Lupus Erythematosus | 2.8 | 1.8 | 0.56 |
| Tic Disorder | 0.8 | -0.8 | |
| Tourette syndrome | 0.2 | 0.2 | |
| Type 1 Diabetes | 2 | 3 | -0.5 |
| Type 2 Diabetes | 4.5 | 3.5 | 0.29 |
| Ulcerative colitis | 4.6 | 4.5 | 0.02 |
| Unhealthy Ageing | 1.8 | 1.8 | |
| Vitiligo | 0.6 | 0.5 | 0.2 |
